Dissecting FGF Signalling to Target Cellular Crosstalk in Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis with a 5 year survival rate of less than 8%, and is predicted to become the second leading cause of cancer-related death by 2030. Alongside late detection, which impacts upon surgical treatment, PDAC tumours are challenging to treat due to...

Full description

Bibliographic Details

Published in:	Cells
Main Authors:	Edward P. Carter, Abigail S. Coetzee, Elena Tomas Bort, Qiaoying Wang, Hemant M. Kocher, Richard P. Grose
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Subjects:	pancreatic cancer FGF signalling crosstalk stroma targeted therapy
Online Access:	https://www.mdpi.com/2073-4409/10/4/847